In light of the literature presented here, further basic research is warranted in order to establish possible therapeutic strategies for ovarian, thyroid and pancreatic cancer, where a pro-tumorigenic role for SIRT1 has been established. This evidence concerns the gene SIRT1 and pancreatic neoplasm.